| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 SOX15 NCOR2 ARID1B POLR1A TOX SUPT6H BRD4 CHD6 CHD7 HSF1 ARID1A ADNP NFAT5 TOX2 TASOR EP300 | 5.35e-09 | 739 | 81 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 BCL9L ARID1B KMT2D BRD4 WWTR1 ARID1A SS18 TOX2 MAML3 EP300 | 3.87e-08 | 303 | 81 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 BCL9L NCOR2 KDM5B ARID1B KMT2D BRD4 WWTR1 ARID1A SS18 TOX2 MAML3 EP300 | 3.94e-07 | 562 | 81 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L NCOR2 KDM5B ARID1B KMT2D BRD4 HGS WWTR1 ARID1A SS18 TOX2 MAML3 EP300 WNK3 HNRNPCL2 | 1.42e-05 | 1160 | 81 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L NCOR2 KDM5B ARID1B KMT2D BRD4 HGS WWTR1 ARID1A SS18 TOX2 GCN1 MAML3 EP300 WNK3 HNRNPCL2 | 2.52e-05 | 1356 | 81 | 17 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 6.97e-05 | 20 | 81 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 NCOR2 GTF2A1 CHD6 TAF4 HSF1 ARID1A NFAT5 TOX2 EP300 DCP1A | 2.23e-04 | 753 | 81 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.87e-04 | 417 | 81 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.52e-04 | 37 | 81 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 5.74e-04 | 9 | 81 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 8.73e-04 | 11 | 81 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.23e-03 | 13 | 81 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 1.23e-03 | 13 | 81 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.44e-03 | 120 | 81 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.91e-03 | 320 | 81 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.10e-03 | 326 | 81 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 2.12e-03 | 17 | 81 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.45e-03 | 66 | 81 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.45e-03 | 66 | 81 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.47e-03 | 582 | 81 | 8 | GO:0140297 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RTF1 SOX15 GTF2A1 KDM5B ARID1B KMT2D EYA4 TOX SUPT6H BRD4 BICRAL CHD6 CHD7 TAF4 ARID1A NFAT5 SS18 TASOR EP300 EMSY | 1.18e-09 | 999 | 81 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | RTF1 SOX15 KDM5B ARID1B KMT2D EYA4 TOX SUPT6H BRD4 BICRAL CHD6 CHD7 ARID1A NFAT5 SS18 TASOR EP300 EMSY | 8.83e-09 | 896 | 81 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 ATMIN BCL9L SOX15 GTF2A1 KMT2D TOX SUPT6H BRD4 WWTR1 CHD6 CHD7 TAF4 PTBP1 HSF1 NFAT5 SS18 TOX2 MAML3 PLSCR1 EP300 SMAD5 | 1.14e-08 | 1390 | 81 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM5B ARID1B KMT2D SUPT6H BRD4 BICRAL CHD6 CHD7 ARID1A NFAT5 SS18 TASOR EP300 | 5.90e-06 | 741 | 81 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | developmental growth | RTF1 SOX15 KDM5B KMT2D FMN1 BRD4 MACF1 WWTR1 CHD7 SIK3 HSF1 ADNP EP300 | 5.17e-05 | 911 | 81 | 13 | GO:0048589 |
| GeneOntologyBiologicalProcess | DNA damage response | ATMIN ARID1B EYA4 BRD4 MASTL TAF4 HSF1 ARID1A PSMD14 NFAT5 PLSCR1 EP300 EMSY | 8.71e-05 | 959 | 81 | 13 | GO:0006974 |
| GeneOntologyBiologicalProcess | embryo development | RTF1 TBX15 SOX15 NCOR2 KMT2D EYA4 SUPT6H BRD4 MACF1 CHD7 GRIN2B HSF1 ARID1A TASOR EP300 SMAD5 | 1.26e-04 | 1437 | 81 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.44e-04 | 202 | 81 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.98e-04 | 136 | 81 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | RTF1 TBX15 SOX15 NCOR2 KMT2D SUPT6H BRD4 CHD7 GRIN2B HSF1 ARID1A EP300 | 2.08e-04 | 906 | 81 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | RTF1 TBX15 NCOA2 SOX15 NCOR2 GZF1 ZBTB5 WWTR1 HSF1 ARID1A EP300 ZBTB24 SMAD5 | 2.20e-04 | 1053 | 81 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 2.42e-04 | 31 | 81 | 3 | GO:0043373 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | RTF1 TBX15 SOX15 NCOR2 KMT2D SUPT6H BRD4 CHD7 GRIN2B HSF1 ARID1A EP300 | 2.61e-04 | 929 | 81 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 2.92e-04 | 33 | 81 | 3 | GO:0002363 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 3.49e-04 | 35 | 81 | 3 | GO:0043369 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 3.49e-04 | 238 | 81 | 6 | GO:0048639 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RTF1 TBX15 NCOA2 SOX15 NCOR2 KDM5B GZF1 ZBTB5 WWTR1 HSF1 ARID1A TASOR EP300 ZBTB24 SMAD5 | 3.55e-04 | 1413 | 81 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.63e-04 | 155 | 81 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 3.82e-04 | 242 | 81 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 3.82e-04 | 242 | 81 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 3.84e-04 | 87 | 81 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 4.20e-04 | 8 | 81 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 4.45e-04 | 162 | 81 | 5 | GO:0072073 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.45e-04 | 162 | 81 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BCL9L ARID1B TOX BRD4 GDF6 MACF1 WWTR1 HSF1 ARID1A ADNP SCIN EP300 SMAD5 | 4.76e-04 | 1141 | 81 | 13 | GO:0045597 |
| GeneOntologyBiologicalProcess | in utero embryonic development | 5.42e-04 | 596 | 81 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 6.00e-04 | 42 | 81 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 6.00e-04 | 42 | 81 | 3 | GO:0002360 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RTF1 TBX15 RGPD4 NCOA2 BCL9L NCOR2 GTF2A1 ARID1B KMT2D POLR1A PRPF40B PTBP2 SUPT6H BRD4 BICRAL TAF4 NUP58 ARID1A ADNP SS18 HNRNPCL2 SMAD5 | 7.52e-09 | 1377 | 81 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | TBX15 NCOA2 BCL9L SOX15 NCOR2 GTF2A1 WWTR1 TAF4 ADNP NFAT5 EP300 SMAD5 DCP1A | 4.59e-07 | 596 | 81 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | TBX15 NCOA2 SOX15 NCOR2 KDM5B ARID1B BRD4 ZBTB5 BICRAL CHD6 CHD7 TAF4 HSF1 ARID1A ADNP NFAT5 SS18 TASOR EP300 SMAD5 | 6.35e-07 | 1480 | 81 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF complex | 5.31e-06 | 30 | 81 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 1.98e-05 | 14 | 81 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.30e-04 | 96 | 81 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | bBAF complex | 6.54e-04 | 10 | 81 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 6.59e-04 | 272 | 81 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 9.78e-04 | 113 | 81 | 4 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 1.08e-03 | 116 | 81 | 4 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 1.18e-03 | 119 | 81 | 4 | GO:0030880 | |
| GeneOntologyCellularComponent | GBAF complex | 1.31e-03 | 14 | 81 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 1.31e-03 | 14 | 81 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.34e-03 | 56 | 81 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | ATPase complex | 1.60e-03 | 129 | 81 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | nBAF complex | 1.72e-03 | 16 | 81 | 2 | GO:0071565 | |
| HumanPheno | Hernia of the abdominal wall | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 MAMLD1 CHD7 GRIN2B TAF4 ARID1A ADNP ZBTB24 WNK3 | 8.25e-08 | 506 | 28 | 14 | HP:0004299 |
| HumanPheno | Abnormal 5th finger morphology | TBX15 RPGRIP1 KDM5B ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ARID1A ADNP EP300 | 8.90e-08 | 509 | 28 | 14 | HP:0004207 |
| HumanPheno | Abdominal wall defect | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 MAMLD1 CHD7 GRIN2B TAF4 ARID1A ADNP ZBTB24 WNK3 | 9.36e-08 | 511 | 28 | 14 | HP:0010866 |
| HumanPheno | Thoracoabdominal wall defect | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 MAMLD1 CHD7 GRIN2B TAF4 ARID1A ADNP ZBTB24 WNK3 | 9.36e-08 | 511 | 28 | 14 | HP:0100656 |
| HumanPheno | Abnormality of the abdominal wall | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 MAMLD1 CHD7 GRIN2B TAF4 ARID1A ADNP ZBTB24 WNK3 | 2.98e-07 | 560 | 28 | 14 | HP:0004298 |
| HumanPheno | Inguinal hernia | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GRIN2B TAF4 ARID1A ADNP WNK3 | 3.21e-07 | 312 | 28 | 11 | HP:0000023 |
| HumanPheno | Cryptorchidism | RPGRIP1 KDM5B ARID1B KMT2D POLR1A BRD4 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 3.92e-07 | 780 | 28 | 16 | HP:0000028 |
| HumanPheno | Hernia | KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 MAMLD1 CHD7 GRIN2B TAF4 ARID1A ADNP ZBTB24 WNK3 | 5.61e-07 | 589 | 28 | 14 | HP:0100790 |
| HumanPheno | Abnormal spermatogenesis | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 6.73e-07 | 1190 | 28 | 19 | HP:0008669 |
| HumanPheno | Abnormal male internal genitalia morphology | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 1.38e-06 | 1243 | 28 | 19 | HP:0000022 |
| HumanPheno | Radial deviation of finger | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 WNK3 | 1.52e-06 | 448 | 28 | 12 | HP:0009466 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 WNK3 | 1.84e-06 | 456 | 28 | 12 | HP:0009485 |
| HumanPheno | Abnormal testis morphology | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 1.94e-06 | 1129 | 28 | 18 | HP:0000035 |
| HumanPheno | Functional abnormality of male internal genitalia | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 1.94e-06 | 1269 | 28 | 19 | HP:0000025 |
| HumanPheno | Non-obstructive azoospermia | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 2.02e-06 | 1132 | 28 | 18 | HP:0011961 |
| HumanPheno | Abnormality of the male genitalia | TBX15 RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 2.44e-06 | 1437 | 28 | 20 | HP:0010461 |
| HumanPheno | Azoospermia | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 2.83e-06 | 1157 | 28 | 18 | HP:0000027 |
| HumanPheno | Clinodactyly | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ARID1A ADNP EP300 WNK3 | 3.11e-06 | 574 | 28 | 13 | HP:0030084 |
| HumanPheno | Choanal atresia | 3.13e-06 | 123 | 28 | 7 | HP:0000453 | |
| HumanPheno | Abnormal skull base morphology | 3.32e-06 | 242 | 28 | 9 | HP:0002693 | |
| HumanPheno | Abnormal male reproductive system physiology | RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 3.42e-06 | 1314 | 28 | 19 | HP:0012874 |
| HumanPheno | Abnormal thorax morphology | TBX15 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 SIK3 ARID1A ADNP EP300 ZBTB24 WNK3 | 4.07e-06 | 1328 | 28 | 19 | HP:0000765 |
| HumanPheno | Abnormal male external genitalia morphology | TBX15 RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 4.12e-06 | 1329 | 28 | 19 | HP:0000032 |
| HumanPheno | Abnormal internal genitalia | RPGRIP1 KDM5B ARID1B KMT2D VWF GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 CFAP70 ARID1A ADNP EP300 BRWD3 WNK3 | 4.98e-06 | 1498 | 28 | 20 | HP:0000812 |
| HumanPheno | Choanal atresia or stenosis | 5.56e-06 | 134 | 28 | 7 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 5.56e-06 | 134 | 28 | 7 | HP:0000415 | |
| HumanPheno | Clinodactyly of the 5th finger | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 | 6.22e-06 | 420 | 28 | 11 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 | 6.36e-06 | 421 | 28 | 11 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 | 6.36e-06 | 421 | 28 | 11 | HP:0009179 |
| HumanPheno | Abnormal external genitalia | TBX15 RPGRIP1 KDM5B ARID1B KMT2D GZF1 POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 GRIN2B TAF4 ARID1A ADNP EP300 BRWD3 WNK3 | 6.88e-06 | 1372 | 28 | 19 | HP:0000811 |
| HumanPheno | Deviation of finger | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 WNK3 | 1.04e-05 | 537 | 28 | 12 | HP:0004097 |
| HumanPheno | Finger clinodactyly | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 | 1.27e-05 | 452 | 28 | 11 | HP:0040019 |
| HumanPheno | Deviation of the hand or of fingers of the hand | TBX15 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ADNP EP300 WNK3 | 1.73e-05 | 564 | 28 | 12 | HP:0009484 |
| HumanPheno | Joint dislocation | 2.31e-05 | 390 | 28 | 10 | HP:0001373 | |
| HumanPheno | Cerebellar malformation | RPGRIP1 ARID1B KMT2D POLR1A GDF6 MACF1 CHD7 TAF4 SIK3 ARID1A EP300 | 2.59e-05 | 487 | 28 | 11 | HP:0002438 |
| HumanPheno | Abnormality of dental eruption | 2.96e-05 | 240 | 28 | 8 | HP:0006292 | |
| HumanPheno | Long eyelashes | 5.60e-05 | 129 | 28 | 6 | HP:0000527 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 6.03e-05 | 265 | 28 | 8 | HP:0001018 | |
| HumanPheno | Cleft palate | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MAMLD1 CHD7 TAF4 ARID1A EP300 | 6.55e-05 | 643 | 28 | 12 | HP:0000175 |
| HumanPheno | Abnormal hard palate morphology | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MAMLD1 CHD7 TAF4 ARID1A EP300 | 6.97e-05 | 647 | 28 | 12 | HP:0100737 |
| HumanPheno | Low-set ears | TBX15 SLC6A9 ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 TAF4 ADNP EP300 ZBTB24 WNK3 | 7.06e-05 | 761 | 28 | 13 | HP:0000369 |
| HumanPheno | Elbow dislocation | 7.89e-05 | 84 | 28 | 5 | HP:0003042 | |
| HumanPheno | Square face | 7.94e-05 | 16 | 28 | 3 | HP:0000321 | |
| HumanPheno | Abnormal pinna morphology | TBX15 RPGRIP1 SLC6A9 KDM5B ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 TAF4 ARID1A ADNP EP300 ZBTB24 BRWD3 WNK3 | 8.21e-05 | 1299 | 28 | 17 | HP:0000377 |
| HumanPheno | Abnormal toe morphology | TBX15 RPGRIP1 SLC6A9 KDM5B ARID1B KMT2D BRD4 GDF6 CHD7 TAF4 SIK3 ARID1A ADNP EP300 | 8.21e-05 | 893 | 28 | 14 | HP:0001780 |
| HumanPheno | Joint hypermobility | SLC6A9 ARID1B KMT2D GZF1 POLR1A MAMLD1 CHD7 TAF4 ARID1A ADNP EP300 | 9.10e-05 | 557 | 28 | 11 | HP:0001382 |
| HumanPheno | Broad philtrum | 9.32e-05 | 45 | 28 | 4 | HP:0000289 | |
| HumanPheno | Prominent eyelashes | 9.61e-05 | 17 | 28 | 3 | HP:0011231 | |
| HumanPheno | Prominent fingertip pads | 1.02e-04 | 46 | 28 | 4 | HP:0001212 | |
| HumanPheno | Advanced eruption of teeth | 1.02e-04 | 46 | 28 | 4 | HP:0006288 | |
| HumanPheno | Retrognathia | 1.13e-04 | 375 | 28 | 9 | HP:0000278 | |
| HumanPheno | Single transverse palmar crease | 1.20e-04 | 215 | 28 | 7 | HP:0000954 | |
| HumanPheno | Prominent digit pad | 1.20e-04 | 48 | 28 | 4 | HP:0011298 | |
| HumanPheno | Abnormality of the outer ear | TBX15 RPGRIP1 SLC6A9 KDM5B ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 TAF4 ARID1A ADNP EP300 ZBTB24 BRWD3 WNK3 | 1.21e-04 | 1337 | 28 | 17 | HP:0000356 |
| HumanPheno | Hirsutism | 1.24e-04 | 216 | 28 | 7 | HP:0001007 | |
| HumanPheno | Abnormality of the hairline | 1.26e-04 | 294 | 28 | 8 | HP:0009553 | |
| HumanPheno | Abnormal palate morphology | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MAMLD1 CHD6 CHD7 TAF4 SIK3 ARID1A ADNP EP300 ZBTB24 | 1.35e-04 | 1202 | 28 | 16 | HP:0000174 |
| HumanPheno | Intracranial cystic lesion | 1.35e-04 | 219 | 28 | 7 | HP:0010576 | |
| HumanPheno | Orofacial cleft | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MAMLD1 CHD7 TAF4 ARID1A EP300 | 1.40e-04 | 694 | 28 | 12 | HP:0000202 |
| HumanPheno | Craniofacial cleft | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MAMLD1 CHD7 TAF4 ARID1A EP300 | 1.40e-04 | 694 | 28 | 12 | HP:5201015 |
| HumanPheno | Abnormal posterior cranial fossa morphology | 1.43e-04 | 221 | 28 | 7 | HP:0000932 | |
| HumanPheno | Central nervous system cyst | 1.47e-04 | 222 | 28 | 7 | HP:0030724 | |
| HumanPheno | Upper extremity joint dislocation | 1.49e-04 | 96 | 28 | 5 | HP:0030310 | |
| HumanPheno | Thick eyebrow | 1.50e-04 | 154 | 28 | 6 | HP:0000574 | |
| HumanPheno | Self-mutilation | 1.53e-04 | 51 | 28 | 4 | HP:0000742 | |
| HumanPheno | Abnormal location of ears | TBX15 RPGRIP1 SLC6A9 ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 TAF4 ADNP EP300 ZBTB24 WNK3 | 1.56e-04 | 945 | 28 | 14 | HP:0000357 |
| HumanPheno | Abnormal hand morphology | TBX15 RPGRIP1 SLC6A9 ARID1B KMT2D POLR1A BRD4 CHD6 CHD7 TAF4 SIK3 ARID1A ADNP EP300 WNK3 | 1.65e-04 | 1082 | 28 | 15 | HP:0005922 |
| HumanPheno | Hypertelorism | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 SIK3 ADNP EP300 ZBTB24 WNK3 | 1.77e-04 | 830 | 28 | 13 | HP:0000316 |
| HumanPheno | Localized hirsutism | 1.85e-04 | 21 | 28 | 3 | HP:0009889 | |
| HumanPheno | Aplasia/Hypoplasia involving the nose | 1.90e-04 | 401 | 28 | 9 | HP:0009924 | |
| HumanPheno | Dislocated radial head | 1.91e-04 | 54 | 28 | 4 | HP:0003083 | |
| HumanPheno | Abnormal dermatoglyphics | 2.00e-04 | 314 | 28 | 8 | HP:0007477 | |
| HumanPheno | Abnormality of globe location or size | TBX15 RPGRIP1 ARID1B KMT2D POLR1A BRD4 GDF6 MACF1 CHD6 CHD7 TAF4 SIK3 ADNP EP300 ZBTB24 WNK3 | 2.12e-04 | 1246 | 28 | 16 | HP:0000489 |
| HumanPheno | Depressed nasal bridge | SLC6A9 ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 ARID1A ADNP EP300 ZBTB24 | 2.15e-04 | 612 | 28 | 11 | HP:0005280 |
| HumanPheno | Flattened nasal bridge | SLC6A9 ARID1B KMT2D POLR1A BRD4 MACF1 CHD7 ARID1A ADNP EP300 ZBTB24 | 2.15e-04 | 612 | 28 | 11 | HP:0000425 |
| HumanPheno | Abnormality of the radial head | 2.36e-04 | 57 | 28 | 4 | HP:0003995 | |
| HumanPheno | Congenital abnormal hair pattern | 2.64e-04 | 327 | 28 | 8 | HP:0011361 | |
| HumanPheno | Abnormality of the humeroradial joint | 3.27e-04 | 62 | 28 | 4 | HP:0100744 | |
| HumanPheno | Atrial septal defect | 3.74e-04 | 541 | 28 | 10 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 3.74e-04 | 541 | 28 | 10 | HP:0001630 | |
| HumanPheno | Low posterior hairline | 3.78e-04 | 117 | 28 | 5 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 3.78e-04 | 117 | 28 | 5 | HP:0030141 | |
| HumanPheno | Abnormality of the palmar creases | 3.91e-04 | 260 | 28 | 7 | HP:0010490 | |
| HumanPheno | Abnormal atrial septum morphology | 3.91e-04 | 544 | 28 | 10 | HP:0011994 | |
| HumanPheno | Abnormality of lower limb joint | TBX15 SLC6A9 KDM5B ARID1B KMT2D POLR1A BRD4 GDF6 MACF1 TAF4 SIK3 ADNP EP300 WNK3 | 3.91e-04 | 1027 | 28 | 14 | HP:0100491 |
| HumanPheno | Abnormality of the dentition | TBX15 ARID1B KMT2D POLR1A ASL BRD4 CHD6 CHD7 TAF4 ARID1A ADNP LYST EP300 WNK3 | 4.04e-04 | 1030 | 28 | 14 | HP:0000164 |
| HumanPheno | Feeding difficulties | KDM5B ARID1B KMT2D POLR1A ASL BRD4 MAMLD1 MACF1 CHD7 GRIN2B TAF4 SIK3 ARID1A ADNP EP300 | 4.05e-04 | 1168 | 28 | 15 | HP:0011968 |
| HumanPheno | Prominent interphalangeal joints | 4.31e-04 | 6 | 28 | 2 | HP:0006237 | |
| HumanPheno | Short palpebral fissure | 4.59e-04 | 122 | 28 | 5 | HP:0012745 | |
| HumanPheno | Abnormal cardiac septum morphology | KDM5B ARID1B KMT2D POLR1A BRD4 GDF6 MACF1 CHD7 SIK3 ARID1A ADNP EP300 | 4.71e-04 | 787 | 28 | 12 | HP:0001671 |
| HumanPheno | Abnormal external nose morphology | RPGRIP1 SLC6A9 KDM5B ARID1B KMT2D POLR1A BRD4 CHD6 TAF4 ARID1A ADNP EP300 ZBTB24 | 4.89e-04 | 916 | 28 | 13 | HP:0010938 |
| HumanPheno | Short columella | 4.94e-04 | 29 | 28 | 3 | HP:0002000 | |
| HumanPheno | Ankyloglossia | 4.94e-04 | 29 | 28 | 3 | HP:0010296 | |
| HumanPheno | Cupped ear | 4.94e-04 | 69 | 28 | 4 | HP:0000378 | |
| HumanPheno | Short chin | 4.94e-04 | 69 | 28 | 4 | HP:0000331 | |
| HumanPheno | High palate | ARID1B KMT2D POLR1A BRD4 MAMLD1 CHD6 TAF4 SIK3 ARID1A ADNP EP300 ZBTB24 | 5.12e-04 | 794 | 28 | 12 | HP:0000218 |
| HumanPheno | Coloboma | 5.38e-04 | 274 | 28 | 7 | HP:0000589 | |
| HumanPheno | Microtia | 5.42e-04 | 195 | 28 | 6 | HP:0008551 | |
| HumanPheno | Long palpebral fissure | 5.51e-04 | 71 | 28 | 4 | HP:0000637 | |
| HumanPheno | Aplasia/Hypoplasia of the cerebellar vermis | 6.02e-04 | 369 | 28 | 8 | HP:0006817 | |
| MousePheno | embryonic growth arrest | BCL9L URB1 POLR1A MACF1 CHD7 HSF1 ARID1A SS18 TASOR EP300 HNRNPCL2 | 1.07e-06 | 346 | 70 | 11 | MP:0001730 |
| MousePheno | abnormal embryo development | RGPD4 BCL9L NCOR2 URB1 POLR1A BRD4 HGS MACF1 BICRAL CHD7 PTBP1 HSF1 ARID1A SS18 TASOR GCN1 EP300 BRWD3 HNRNPCL2 SMAD5 DCP1A | 1.95e-06 | 1370 | 70 | 21 | MP:0001672 |
| Domain | BAF250_C | 1.77e-05 | 2 | 79 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.77e-05 | 2 | 79 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.77e-05 | 2 | 79 | 2 | IPR021906 | |
| Domain | - | 3.19e-05 | 15 | 79 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 3.19e-05 | 15 | 79 | 3 | SM00501 | |
| Domain | ARID_dom | 3.19e-05 | 15 | 79 | 3 | IPR001606 | |
| Domain | ARID | 3.19e-05 | 15 | 79 | 3 | PS51011 | |
| Domain | ARID | 3.19e-05 | 15 | 79 | 3 | PF01388 | |
| Domain | HMG_box | 7.42e-05 | 53 | 79 | 4 | PF00505 | |
| Domain | HMG | 7.98e-05 | 54 | 79 | 4 | SM00398 | |
| Domain | - | 8.58e-05 | 55 | 79 | 4 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.65e-04 | 65 | 79 | 4 | IPR009071 | |
| Domain | HnRNP-L/PTB | 1.75e-04 | 5 | 79 | 2 | IPR006536 | |
| Domain | BRK | 2.62e-04 | 6 | 79 | 2 | SM00592 | |
| Domain | Nuc_rcpt_coact | 2.62e-04 | 6 | 79 | 2 | IPR009110 | |
| Domain | BRK_domain | 2.62e-04 | 6 | 79 | 2 | IPR006576 | |
| Domain | BRK | 2.62e-04 | 6 | 79 | 2 | PF07533 | |
| Domain | BROMODOMAIN_1 | 5.10e-04 | 37 | 79 | 3 | PS00633 | |
| Domain | Bromodomain | 5.52e-04 | 38 | 79 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 6.92e-04 | 41 | 79 | 3 | PS50014 | |
| Domain | BROMO | 7.42e-04 | 42 | 79 | 3 | SM00297 | |
| Domain | Bromodomain | 7.42e-04 | 42 | 79 | 3 | IPR001487 | |
| Domain | - | 7.42e-04 | 42 | 79 | 3 | 1.20.920.10 | |
| Domain | WW | 1.03e-03 | 47 | 79 | 3 | PF00397 | |
| Domain | WW | 1.10e-03 | 48 | 79 | 3 | SM00456 | |
| Domain | SANT | 1.24e-03 | 50 | 79 | 3 | SM00717 | |
| Domain | WW_DOMAIN_2 | 1.31e-03 | 51 | 79 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.31e-03 | 51 | 79 | 3 | PS01159 | |
| Domain | WW_dom | 1.39e-03 | 52 | 79 | 3 | IPR001202 | |
| Domain | SANT/Myb | 1.39e-03 | 52 | 79 | 3 | IPR001005 | |
| Domain | HMG_BOX_2 | 1.55e-03 | 54 | 79 | 3 | PS50118 | |
| Domain | Chromo_domain | 4.59e-03 | 24 | 79 | 2 | IPR023780 | |
| Domain | Bromodomain_CS | 5.38e-03 | 26 | 79 | 2 | IPR018359 | |
| Domain | Chromo | 5.38e-03 | 26 | 79 | 2 | PF00385 | |
| Domain | CHROMO_1 | 6.22e-03 | 28 | 79 | 2 | PS00598 | |
| Domain | CHROMO_2 | 6.22e-03 | 28 | 79 | 2 | PS50013 | |
| Domain | SNF2_N | 8.07e-03 | 32 | 79 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 8.07e-03 | 32 | 79 | 2 | IPR016197 | |
| Domain | SNF2_N | 8.07e-03 | 32 | 79 | 2 | PF00176 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 7.37e-06 | 10 | 57 | 3 | MM15535 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD4 NCOR2 GTF2A1 KDM5B KMT2D POLR1A SUPT6H MAMLD1 WWTR1 TAF4 NUP58 ARID1A PSMD14 MAML3 EP300 | 8.87e-06 | 1022 | 57 | 15 | MM15436 |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.34e-05 | 12 | 57 | 3 | M27159 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.21e-05 | 14 | 57 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.38e-05 | 16 | 57 | 3 | M27121 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.09e-05 | 48 | 57 | 4 | M611 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 4.17e-05 | 96 | 57 | 5 | M27784 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.90e-05 | 18 | 57 | 3 | MM14775 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.80e-05 | 20 | 57 | 3 | M27881 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 6.96e-05 | 254 | 57 | 7 | M27131 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 8.66e-05 | 58 | 57 | 4 | M29616 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.05e-04 | 23 | 57 | 3 | MM14954 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.07e-04 | 272 | 57 | 7 | M29619 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.35e-04 | 25 | 57 | 3 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.53e-04 | 26 | 57 | 3 | M2499 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.53e-04 | 26 | 57 | 3 | MM14793 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.71e-04 | 69 | 57 | 4 | M46439 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.91e-04 | 28 | 57 | 3 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.24e-04 | 74 | 57 | 4 | M616 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.35e-04 | 30 | 57 | 3 | M207 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.48e-04 | 76 | 57 | 4 | MM15520 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | RTF1 NCOR2 GTF2A1 KDM5B ARID1B KMT2D SUPT6H MAMLD1 WWTR1 GRIN2B TAF4 ARID1A PSMD14 MAML3 EP300 | 2.99e-04 | 1387 | 57 | 15 | M734 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.14e-04 | 33 | 57 | 3 | M604 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 3.17e-04 | 81 | 57 | 4 | M865 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 3.32e-04 | 82 | 57 | 4 | M594 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 3.33e-04 | 7 | 57 | 2 | M6907 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.34e-04 | 158 | 57 | 5 | MM14791 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.42e-04 | 37 | 57 | 3 | M27797 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.15e-04 | 92 | 57 | 4 | MM14951 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.17e-04 | 39 | 57 | 3 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 6.43e-04 | 42 | 57 | 3 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 6.43e-04 | 42 | 57 | 3 | M17541 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.92e-04 | 175 | 57 | 5 | MM14941 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 7.38e-04 | 44 | 57 | 3 | M27295 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 8.96e-04 | 47 | 57 | 3 | M7946 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | NCOR2 KDM5B KMT2D MAMLD1 WWTR1 TAF4 ARID1A PSMD14 MAML3 EP300 | 9.12e-04 | 768 | 57 | 10 | MM14851 |
| Pathway | WP_RETT_SYNDROME | 9.53e-04 | 48 | 57 | 3 | M39759 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.01e-03 | 49 | 57 | 3 | M618 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.03e-03 | 12 | 57 | 2 | M22006 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.14e-03 | 51 | 57 | 3 | M665 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.22e-03 | 13 | 57 | 2 | MM14952 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.22e-03 | 13 | 57 | 2 | MM15622 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.65e-03 | 58 | 57 | 3 | MM15149 | |
| Pathway | REACTOME_GASTRULATION | 1.82e-03 | 129 | 57 | 4 | M46433 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.91e-03 | 61 | 57 | 3 | M39540 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.10e-03 | 63 | 57 | 3 | MM15613 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.19e-03 | 64 | 57 | 3 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.29e-03 | 65 | 57 | 3 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.36e-03 | 18 | 57 | 2 | MM15034 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.36e-03 | 18 | 57 | 2 | M26942 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.46e-03 | 233 | 57 | 5 | M27099 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.58e-03 | 142 | 57 | 4 | M48257 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.65e-03 | 237 | 57 | 5 | M27786 | |
| Pubmed | 2.08e-11 | 83 | 81 | 8 | 28794006 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 BCL9L NCOR2 ARID1B KMT2D EYA4 CHD7 TAF4 NUP58 ARID1A EP300 EMSY | 3.51e-11 | 351 | 81 | 12 | 38297188 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 BCL9L NCOR2 ARID1B KMT2D PRPF40B MAMLD1 WWTR1 NUP58 ARID1A ANKHD1 MAML3 EP300 | 4.90e-11 | 457 | 81 | 13 | 32344865 |
| Pubmed | NCOA2 BCL9L SOX15 NCOR2 ARID1B KMT2D EYA4 HGS CHD6 CHD7 TAF4 ARID1A ANKHD1 ADNP PSMD14 SS18 EP300 EMSY SMAD5 DCP1A | 7.07e-11 | 1429 | 81 | 20 | 35140242 | |
| Pubmed | 1.32e-10 | 225 | 81 | 10 | 12168954 | ||
| Pubmed | RGPD4 NCOR2 KDM5B KMT2D BRD4 CHD6 CHD7 ANKHD1 ADNP TASOR GCN1 DCP1A | 2.60e-10 | 418 | 81 | 12 | 34709266 | |
| Pubmed | NCOA2 ARID1B KMT2D BRD4 WWTR1 TAF4 ARID1A ANKHD1 ADNP GCN1 EP300 EMSY DCP1A | 4.63e-10 | 549 | 81 | 13 | 38280479 | |
| Pubmed | GTF2A1 VWF HGS MACF1 WWTR1 BICRAL CHD6 NUP58 SIK3 SS18 GCN1 EP300 | 1.43e-09 | 486 | 81 | 12 | 20936779 | |
| Pubmed | 3.51e-09 | 157 | 81 | 8 | 30186101 | ||
| Pubmed | 4.69e-09 | 27 | 81 | 5 | 29374058 | ||
| Pubmed | 1.36e-08 | 33 | 81 | 5 | 19336002 | ||
| Pubmed | NCOA2 NCOR2 ARID1B KMT2D MUC16 CHD6 CHD7 SIK3 ARID1A SS18 MAML3 EP300 | 2.93e-08 | 638 | 81 | 12 | 31182584 | |
| Pubmed | 2.97e-08 | 78 | 81 | 6 | 28611094 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOR2 URB1 KMT2D EYA4 SUPT6H BRD4 WWTR1 CHD6 CHD7 TAF4 PTBP1 ARID1A ADNP TASOR EP300 EMSY | 4.23e-08 | 1294 | 81 | 16 | 30804502 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.88e-08 | 220 | 81 | 8 | 35785414 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 8.70e-08 | 444 | 81 | 10 | 34795231 | |
| Pubmed | TBX15 NCOA2 GTF2A1 KDM5B TOX BRD4 MACF1 ARID1A PSMD14 NFAT5 MAML3 DCP1A | 9.20e-08 | 709 | 81 | 12 | 22988430 | |
| Pubmed | Hgs physically interacts with Smad5 and attenuates BMP signaling. | 1.21e-07 | 5 | 81 | 3 | 16516194 | |
| Pubmed | 1.44e-07 | 469 | 81 | 10 | 27634302 | ||
| Pubmed | 2.22e-07 | 268 | 81 | 8 | 33640491 | ||
| Pubmed | NCOA2 NCOR2 ARID1B KMT2D BRD4 BICRAL CHD7 TAF4 PTBP1 ARID1A ADNP PSMD14 EP300 EMSY | 2.42e-07 | 1103 | 81 | 14 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOR2 ARID1B PTBP2 BRD4 CHD7 TAF4 PTBP1 ARID1A ADNP SS18 TASOR EMSY HNRNPCL2 | 3.08e-07 | 954 | 81 | 13 | 36373674 |
| Pubmed | TBX15 NCOA2 SOX15 GTF2A1 KDM5B TOX BRD4 ZBTB5 HSF1 ARID1A NFAT5 ZBTB24 | 3.72e-07 | 808 | 81 | 12 | 20412781 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.88e-07 | 398 | 81 | 9 | 35016035 | |
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 23540691 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TBX15 NCOA2 SOX15 NCOR2 GTF2A1 POLR1A ZBTB5 WWTR1 MAML3 EP300 ZBTB24 SMAD5 | 8.80e-07 | 877 | 81 | 12 | 20211142 |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 1.01e-06 | 9 | 81 | 3 | 27325115 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B ARID1B PTBP2 SUPT6H BRD4 MACF1 CHD6 CHD7 SIK3 PTBP1 ARID1A ADNP GCN1 | 1.26e-06 | 1082 | 81 | 13 | 38697112 |
| Pubmed | NCOA2 URB1 ARID1B PTBP2 FMN1 MASTL MACF1 CHD7 ANKHD1 NFAT5 TASOR ZBTB24 DCP1A | 1.29e-06 | 1084 | 81 | 13 | 11544199 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SHISA9 NCOA2 ATMIN NCOR2 POLR1A PTBP2 SUPT6H MACF1 CHD6 TAF4 ARID1A NFAT5 MAML3 EP300 BRWD3 | 1.58e-06 | 1489 | 81 | 15 | 28611215 |
| Pubmed | NCOR2 ARID1B PRPF40B BRD4 MACF1 BICRAL TAF4 SIK3 ARID1A ANKHD1 SS18 EP300 BRWD3 | 1.77e-06 | 1116 | 81 | 13 | 31753913 | |
| Pubmed | RGPD4 NCOA2 NCOR2 HECW1 MACF1 CHD7 GRIN2B TAF4 SIK3 ADNP EMSY WNK3 | 2.32e-06 | 963 | 81 | 12 | 28671696 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.34e-06 | 40 | 81 | 4 | 34585037 | |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 11734557 | ||
| Pubmed | 4.14e-06 | 46 | 81 | 4 | 20301533 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.16e-06 | 180 | 81 | 6 | 35198878 | |
| Pubmed | 4.57e-06 | 183 | 81 | 6 | 36129980 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35715442 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24581496 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18331477 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28104499 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28475860 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 5.36e-06 | 2 | 81 | 2 | 37611161 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32791957 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11030627 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 5.36e-06 | 2 | 81 | 2 | 28967863 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21768390 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34386776 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23202128 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12213192 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33890484 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27681424 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 5.36e-06 | 2 | 81 | 2 | 24562383 | |
| Pubmed | TAZ suppresses NFAT5 activity through tyrosine phosphorylation. | 5.36e-06 | 2 | 81 | 2 | 23045390 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24733925 | ||
| Pubmed | Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1. | 5.36e-06 | 2 | 81 | 2 | 35405117 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35111387 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 5.36e-06 | 2 | 81 | 2 | 29890703 | |
| Pubmed | Two distinct mechanisms of RNA polymerase II elongation stimulation in vivo. | 5.36e-06 | 2 | 81 | 2 | 34146481 | |
| Pubmed | The bromodomain protein BRD4 regulates splicing during heat shock. | 5.36e-06 | 2 | 81 | 2 | 27536004 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24788099 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33052929 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17606642 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 5.36e-06 | 2 | 81 | 2 | 27562491 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 5.38e-06 | 411 | 81 | 8 | 35182466 | |
| Pubmed | 5.43e-06 | 15 | 81 | 3 | 23785148 | ||
| Pubmed | 7.94e-06 | 733 | 81 | 10 | 34672954 | ||
| Pubmed | 8.08e-06 | 17 | 81 | 3 | 19183483 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 8.28e-06 | 203 | 81 | 6 | 22083510 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 9.39e-06 | 588 | 81 | 9 | 38580884 | |
| Pubmed | 9.78e-06 | 591 | 81 | 9 | 15231748 | ||
| Pubmed | 9.82e-06 | 57 | 81 | 4 | 18022353 | ||
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 1.05e-05 | 58 | 81 | 4 | 37117185 | |
| Pubmed | 1.10e-05 | 124 | 81 | 5 | 20850016 | ||
| Pubmed | 1.21e-05 | 60 | 81 | 4 | 19075228 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.23e-05 | 608 | 81 | 9 | 36089195 | |
| Pubmed | 1.29e-05 | 61 | 81 | 4 | 20305087 | ||
| Pubmed | 1.35e-05 | 20 | 81 | 3 | 11877444 | ||
| Pubmed | 1.47e-05 | 472 | 81 | 8 | 38943005 | ||
| Pubmed | 1.57e-05 | 21 | 81 | 3 | 19596656 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21647563 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28007623 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 37410700 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28262505 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12667457 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27387124 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23708190 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28533432 | ||
| Pubmed | Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. | 1.60e-05 | 3 | 81 | 2 | 30224758 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34512623 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 30631061 | ||
| Pubmed | MRG15 is required for pre-mRNA splicing and spermatogenesis. | 1.60e-05 | 3 | 81 | 2 | 27573846 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 33432679 | ||
| Pubmed | Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. | 1.60e-05 | 3 | 81 | 2 | 32544088 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.60e-05 | 3 | 81 | 2 | 26716708 | |
| Pubmed | BMP signaling initiates a neural crest differentiation program in embryonic rat CNS stem cells. | 1.60e-05 | 3 | 81 | 2 | 15246821 | |
| Pubmed | Expression of human nPTB is limited by extreme suboptimal codon content. | 1.60e-05 | 3 | 81 | 2 | 18335065 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 20676058 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11518802 | ||
| Interaction | TLE3 interactions | TBX15 NCOA2 BCL9L SOX15 NCOR2 ARID1B KMT2D PRPF40B BRD4 MASTL CHD6 TAF4 ARID1A EP300 EMSY | 1.60e-11 | 376 | 79 | 15 | int:TLE3 |
| Interaction | TBR1 interactions | 5.88e-10 | 113 | 79 | 9 | int:TBR1 | |
| Interaction | SOX7 interactions | 1.09e-09 | 82 | 79 | 8 | int:SOX7 | |
| Interaction | PAX9 interactions | 2.06e-09 | 130 | 79 | 9 | int:PAX9 | |
| Interaction | FEV interactions | 6.78e-09 | 203 | 79 | 10 | int:FEV | |
| Interaction | ETV4 interactions | 9.62e-09 | 69 | 79 | 7 | int:ETV4 | |
| Interaction | NUP35 interactions | NCOA2 BCL9L NCOR2 ARID1B KMT2D PRPF40B MAMLD1 WWTR1 NUP58 ARID1A ANKHD1 MAML3 EP300 | 9.87e-09 | 424 | 79 | 13 | int:NUP35 |
| Interaction | HNF4A interactions | NCOA2 NCOR2 ARID1B KMT2D CHD7 TAF4 ARID1A ADNP SS18 EP300 EMSY | 9.95e-09 | 275 | 79 | 11 | int:HNF4A |
| Interaction | ERG interactions | 1.66e-08 | 223 | 79 | 10 | int:ERG | |
| Interaction | TBXT interactions | 1.75e-08 | 116 | 79 | 8 | int:TBXT | |
| Interaction | TLX3 interactions | TBX15 NCOA2 BCL9L NCOR2 ARID1B KMT2D CHD6 CHD7 ARID1A TOX2 EP300 | 1.78e-08 | 291 | 79 | 11 | int:TLX3 |
| Interaction | SNRNP40 interactions | BCL9L NCOR2 URB1 ARID1B PRPF40B PTBP2 SUPT6H BRD4 MASTL TAF4 PTBP1 HSF1 ARID1A TASOR EMSY | 2.21e-08 | 637 | 79 | 15 | int:SNRNP40 |
| Interaction | EGR2 interactions | 2.28e-08 | 171 | 79 | 9 | int:EGR2 | |
| Interaction | SMARCA4 interactions | NCOR2 ARID1B BRD4 WWTR1 BICRAL CHD7 SIK3 HSF1 ARID1A ADNP SS18 EP300 TIPARP | 2.72e-08 | 462 | 79 | 13 | int:SMARCA4 |
| Interaction | PAX7 interactions | 2.96e-08 | 124 | 79 | 8 | int:PAX7 | |
| Interaction | IRF4 interactions | 4.19e-08 | 85 | 79 | 7 | int:IRF4 | |
| Interaction | HNF1B interactions | 5.67e-08 | 190 | 79 | 9 | int:HNF1B | |
| Interaction | SUPT5H interactions | RTF1 NCOR2 ARID1B KMT2D EYA4 SUPT6H BRD4 CHD7 ARID1A TASOR MAML3 EP300 | 6.08e-08 | 408 | 79 | 12 | int:SUPT5H |
| Interaction | DTX2 interactions | TBX15 SLC6A9 BCL9L NCOR2 EYA4 HGS WWTR1 BICRAL NUP58 TASOR PLSCR1 | 6.44e-08 | 330 | 79 | 11 | int:DTX2 |
| Interaction | KLF5 interactions | 7.09e-08 | 195 | 79 | 9 | int:KLF5 | |
| Interaction | SOX10 interactions | 7.27e-08 | 92 | 79 | 7 | int:SOX10 | |
| Interaction | SOX15 interactions | 8.07e-08 | 141 | 79 | 8 | int:SOX15 | |
| Interaction | GATA2 interactions | 8.44e-08 | 199 | 79 | 9 | int:GATA2 | |
| Interaction | SOX17 interactions | 9.09e-08 | 95 | 79 | 7 | int:SOX17 | |
| Interaction | NCOA6 interactions | 1.00e-07 | 145 | 79 | 8 | int:NCOA6 | |
| Interaction | ELF5 interactions | 1.11e-07 | 147 | 79 | 8 | int:ELF5 | |
| Interaction | ARID1A interactions | 1.24e-07 | 276 | 79 | 10 | int:ARID1A | |
| Interaction | BICRA interactions | 2.47e-07 | 67 | 79 | 6 | int:BICRA | |
| Interaction | PAX8 interactions | 2.66e-07 | 111 | 79 | 7 | int:PAX8 | |
| Interaction | KLF3 interactions | 2.68e-07 | 228 | 79 | 9 | int:KLF3 | |
| Interaction | GCM1 interactions | 2.70e-07 | 68 | 79 | 6 | int:GCM1 | |
| Interaction | SP7 interactions | 3.02e-07 | 304 | 79 | 10 | int:SP7 | |
| Interaction | EP300 interactions | RTF1 NCOA2 SOX15 NCOR2 KMT2D EYA4 PTBP2 SUPT6H BRD4 ZBTB5 WWTR1 PTBP1 HSF1 ARID1A SS18 GCN1 PLSCR1 EP300 TIPARP SMAD5 | 3.06e-07 | 1401 | 79 | 20 | int:EP300 |
| Interaction | TLX1 interactions | 4.25e-07 | 175 | 79 | 8 | int:TLX1 | |
| Interaction | NOVA2 interactions | 5.01e-07 | 17 | 79 | 4 | int:NOVA2 | |
| Interaction | KDM1A interactions | NCOR2 KDM5B KMT2D BRD4 CAGE1 CHD6 CHD7 HSF1 ANKHD1 ADNP TASOR GCN1 EP300 ZBTB24 TIPARP DCP1A | 6.09e-07 | 941 | 79 | 16 | int:KDM1A |
| Interaction | CRX interactions | 6.65e-07 | 254 | 79 | 9 | int:CRX | |
| Interaction | NFIA interactions | 7.32e-07 | 188 | 79 | 8 | int:NFIA | |
| Interaction | WWTR1 interactions | NCOA2 ARID1B KMT2D BRD4 WWTR1 ARID1A ANKHD1 ADNP GCN1 EP300 EMSY | 7.50e-07 | 422 | 79 | 11 | int:WWTR1 |
| Interaction | BAG2 interactions | RTF1 NCOA2 SUPT6H BRD4 HGS HSF1 ANKHD1 ADNP PSMD14 EP300 BRWD3 WNK3 TIPARP | 8.28e-07 | 622 | 79 | 13 | int:BAG2 |
| Interaction | YAP1 interactions | RTF1 BCL9L ARID1B KMT2D HECW1 BRD4 WWTR1 TAF4 PTBP1 ARID1A ADNP NFAT5 GCN1 EP300 TIPARP SMAD5 DCP1A | 9.05e-07 | 1095 | 79 | 17 | int:YAP1 |
| Interaction | HDAC1 interactions | NCOR2 KDM5B KMT2D BRD4 ZBTB5 HSF1 ARID1A ANKHD1 ADNP SS18 TASOR GCN1 EP300 EMSY TIPARP SMAD5 DCP1A | 1.06e-06 | 1108 | 79 | 17 | int:HDAC1 |
| Interaction | GSC interactions | 1.17e-06 | 87 | 79 | 6 | int:GSC | |
| Interaction | AR interactions | NCOA2 BCL9L NCOR2 KDM5B ARID1B KMT2D BRD4 CHD7 PTBP1 ARID1A ADNP PSMD14 GCN1 EP300 EMSY TIPARP | 1.22e-06 | 992 | 79 | 16 | int:AR |
| Interaction | TERF2IP interactions | RTF1 NCOA2 NCOR2 SUPT6H BRD4 MASTL CHD7 TAF4 ARID1A ADNP TASOR EMSY | 1.53e-06 | 552 | 79 | 12 | int:TERF2IP |
| Interaction | FOXI1 interactions | 1.63e-06 | 92 | 79 | 6 | int:FOXI1 | |
| Interaction | SOX2 interactions | NCOA2 BCL9L NCOR2 KDM5B ARID1B KMT2D PTBP2 ZBTB5 MACF1 CHD6 CHD7 PTBP1 ARID1A ANKHD1 ADNP SS18 GCN1 EP300 TIPARP | 1.75e-06 | 1422 | 79 | 19 | int:SOX2 |
| Interaction | SMARCE1 interactions | 1.83e-06 | 287 | 79 | 9 | int:SMARCE1 | |
| Interaction | ATXN1L interactions | 2.04e-06 | 150 | 79 | 7 | int:ATXN1L | |
| Interaction | SOX9 interactions | 2.23e-06 | 97 | 79 | 6 | int:SOX9 | |
| Interaction | ARID2 interactions | 2.32e-06 | 153 | 79 | 7 | int:ARID2 | |
| Interaction | SS18L1 interactions | 2.36e-06 | 98 | 79 | 6 | int:SS18L1 | |
| Interaction | NCOA3 interactions | 2.72e-06 | 224 | 79 | 8 | int:NCOA3 | |
| Interaction | FOXK2 interactions | 2.81e-06 | 225 | 79 | 8 | int:FOXK2 | |
| Interaction | PML interactions | NCOA2 NCOR2 BRD4 MAMLD1 MASTL ZBTB5 TAF4 HSF1 PSMD14 GCN1 PLSCR1 EP300 EMSY TIPARP DCP1A | 2.88e-06 | 933 | 79 | 15 | int:PML |
| Interaction | TAF9 interactions | 3.00e-06 | 159 | 79 | 7 | int:TAF9 | |
| Interaction | NFIX interactions | 3.00e-06 | 227 | 79 | 8 | int:NFIX | |
| Interaction | RCOR1 interactions | NCOR2 KDM5B KMT2D BRD4 ZBTB5 CHD6 CHD7 ANKHD1 TASOR GCN1 DCP1A | 3.45e-06 | 494 | 79 | 11 | int:RCOR1 |
| Interaction | CREBBP interactions | NCOA2 NCOR2 ARID1B KMT2D EYA4 SUPT6H BRD4 WWTR1 HSF1 ARID1A EP300 TIPARP | 3.55e-06 | 599 | 79 | 12 | int:CREBBP |
| Interaction | FOS interactions | 3.62e-06 | 312 | 79 | 9 | int:FOS | |
| Interaction | LHX4 interactions | 3.99e-06 | 166 | 79 | 7 | int:LHX4 | |
| Interaction | CSNK2A2 interactions | RTF1 GTF2A1 POLR1A ASL BRD4 GRIN2B ADNP GCN1 LYST EP300 BRWD3 EMSY TIPARP | 4.04e-06 | 718 | 79 | 13 | int:CSNK2A2 |
| Interaction | TAF7 interactions | 4.17e-06 | 108 | 79 | 6 | int:TAF7 | |
| Interaction | CEP85 interactions | 4.49e-06 | 169 | 79 | 7 | int:CEP85 | |
| Interaction | CEBPA interactions | NCOA2 RPGRIP1 NCOR2 URB1 ARID1B KMT2D BRD4 MACF1 BICRAL CHD7 TAF4 PTBP1 ARID1A ADNP PSMD14 EP300 EMSY | 5.17e-06 | 1245 | 79 | 17 | int:CEBPA |
| Interaction | KLF8 interactions | 5.57e-06 | 329 | 79 | 9 | int:KLF8 | |
| Interaction | TEAD1 interactions | 5.87e-06 | 176 | 79 | 7 | int:TEAD1 | |
| Interaction | ASF1A interactions | 5.94e-06 | 249 | 79 | 8 | int:ASF1A | |
| Interaction | ARID1B interactions | 6.09e-06 | 177 | 79 | 7 | int:ARID1B | |
| Interaction | CHD3 interactions | KDM5B SUPT6H BRD4 ZBTB5 CHD6 PTBP1 HSF1 ARID1A ADNP PSMD14 EP300 HNRNPCL2 TIPARP | 7.15e-06 | 757 | 79 | 13 | int:CHD3 |
| Interaction | LHX2 interactions | 7.58e-06 | 183 | 79 | 7 | int:LHX2 | |
| Interaction | PBRM1 interactions | 7.71e-06 | 258 | 79 | 8 | int:PBRM1 | |
| Interaction | EYA2 interactions | 8.04e-06 | 121 | 79 | 6 | int:EYA2 | |
| Interaction | BCL7A interactions | 8.83e-06 | 123 | 79 | 6 | int:BCL7A | |
| Interaction | NCOR2 interactions | 9.11e-06 | 264 | 79 | 8 | int:NCOR2 | |
| Interaction | SMARCC2 interactions | 9.81e-06 | 353 | 79 | 9 | int:SMARCC2 | |
| Interaction | MYOD1 interactions | 1.11e-05 | 194 | 79 | 7 | int:MYOD1 | |
| Interaction | E2F5 interactions | 1.17e-05 | 36 | 79 | 4 | int:E2F5 | |
| Interaction | PAX6 interactions | 1.31e-05 | 366 | 79 | 9 | int:PAX6 | |
| Interaction | SSRP1 interactions | RTF1 POLR1A SUPT6H BRD4 WWTR1 HSF1 ARID1A ADNP TASOR EP300 BRWD3 TIPARP | 1.37e-05 | 685 | 79 | 12 | int:SSRP1 |
| Interaction | POU5F1 interactions | SOX15 NCOR2 ARID1B PTBP2 BRD4 MUC16 CHD7 ARID1A TOX2 GCN1 EMSY | 1.67e-05 | 584 | 79 | 11 | int:POU5F1 |
| Interaction | ACTL6A interactions | 1.75e-05 | 289 | 79 | 8 | int:ACTL6A | |
| Interaction | SMARCC1 interactions | 1.91e-05 | 384 | 79 | 9 | int:SMARCC1 | |
| Interaction | NCOA2 interactions | 1.93e-05 | 141 | 79 | 6 | int:NCOA2 | |
| Interaction | NFIB interactions | 2.00e-05 | 142 | 79 | 6 | int:NFIB | |
| Interaction | TLX2 interactions | 2.00e-05 | 142 | 79 | 6 | int:TLX2 | |
| Interaction | BCOR interactions | 2.40e-05 | 302 | 79 | 8 | int:BCOR | |
| Interaction | PPARG interactions | 2.70e-05 | 307 | 79 | 8 | int:PPARG | |
| Interaction | RTF1 interactions | 2.73e-05 | 150 | 79 | 6 | int:RTF1 | |
| Interaction | SMC5 interactions | NCOR2 ARID1B PTBP2 BRD4 CHD7 TAF4 PTBP1 ARID1A ADNP SS18 TASOR EMSY HNRNPCL2 TIPARP | 3.05e-05 | 1000 | 79 | 14 | int:SMC5 |
| Interaction | NUP43 interactions | RTF1 BCL9L NCOR2 ARID1B KMT2D SUPT6H CHD6 CCDC168 TAF4 ARID1A EMSY | 3.12e-05 | 625 | 79 | 11 | int:NUP43 |
| Interaction | MECP2 interactions | KDM5B URB1 ARID1B PRPF40B PTBP2 SUPT6H BRD4 MACF1 CHD6 CHD7 SIK3 PTBP1 ARID1A ADNP GCN1 EP300 | 3.27e-05 | 1287 | 79 | 16 | int:MECP2 |
| Interaction | BUB3 interactions | 3.51e-05 | 232 | 79 | 7 | int:BUB3 | |
| Interaction | SMG7 interactions | 3.55e-05 | 319 | 79 | 8 | int:SMG7 | |
| Interaction | FOXP4 interactions | 4.16e-05 | 98 | 79 | 5 | int:FOXP4 | |
| Interaction | KDM5B interactions | 4.58e-05 | 100 | 79 | 5 | int:KDM5B | |
| Interaction | QSER1 interactions | 4.58e-05 | 100 | 79 | 5 | int:QSER1 | |
| Interaction | CDC16 interactions | 5.09e-05 | 246 | 79 | 7 | int:CDC16 | |
| Interaction | LHX1 interactions | 5.28e-05 | 103 | 79 | 5 | int:LHX1 | |
| Interaction | SCYL1 interactions | 5.33e-05 | 169 | 79 | 6 | int:SCYL1 | |
| GeneFamily | AT-rich interaction domain containing | 9.39e-06 | 15 | 51 | 3 | 418 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.65e-05 | 25 | 51 | 3 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.48e-04 | 53 | 51 | 3 | 532 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.03e-03 | 17 | 51 | 2 | 486 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.62e-03 | 36 | 51 | 2 | 823 | |
| Coexpression | GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 2.52e-08 | 155 | 80 | 8 | M8913 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 2.57e-07 | 141 | 80 | 7 | M39235 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 NCOR2 KDM5B MAMLD1 MACF1 WWTR1 BICRAL TAF4 SIK3 ADNP TASOR PLSCR1 TIPARP | 1.83e-06 | 856 | 80 | 13 | M4500 |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 2.43e-06 | 197 | 80 | 7 | M4421 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 2.52e-06 | 198 | 80 | 7 | M4415 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 8.90e-06 | 240 | 80 | 7 | M39236 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.90e-05 | 180 | 80 | 6 | M8239 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN | 3.07e-05 | 196 | 80 | 6 | M3143 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | 3.25e-05 | 198 | 80 | 6 | M7708 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 3.35e-05 | 199 | 80 | 6 | M9964 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 3.44e-05 | 200 | 80 | 6 | M8997 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 6.82e-05 | 139 | 80 | 5 | M8948 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TOX PTBP2 FMN1 MAMLD1 MACF1 CHD7 ARID1A ADNP SCIN TOX2 MAML3 BRWD3 TIPARP SMAD5 | 1.76e-05 | 989 | 80 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | GTF2A1 EYA4 TOX PTBP2 BRD4 GDF6 MASTL MACF1 CHD7 ADNP SS18 BRWD3 EMSY TIPARP SMAD5 | 5.34e-05 | 1241 | 80 | 15 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | GTF2A1 EYA4 TOX PTBP2 BRD4 GDF6 MASTL MACF1 ARID1A ADNP PSMD14 EMSY WNK3 TIPARP SMAD5 | 6.17e-05 | 1257 | 80 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | GTF2A1 EYA4 TOX PTBP2 BRD4 GDF6 MASTL MACF1 CHD7 ARID1A ADNP PSMD14 EMSY WNK3 TIPARP SMAD5 | 9.23e-05 | 1459 | 80 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.23e-04 | 629 | 80 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NCOA2 URB1 EYA4 TOX PTBP2 MAMLD1 MASTL MACF1 CHD7 ARID1A EMSY WNK3 SMAD5 | 1.56e-04 | 1060 | 80 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.75e-04 | 312 | 80 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.22e-04 | 432 | 80 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NCOA2 URB1 EYA4 TOX PTBP2 MAMLD1 MASTL MACF1 CHD7 ARID1A TOX2 EMSY WNK3 ALOX15 SMAD5 | 2.28e-04 | 1414 | 80 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.37e-08 | 193 | 81 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.54e-07 | 164 | 81 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 8.37e-07 | 176 | 81 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 8.65e-07 | 177 | 81 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.16e-06 | 186 | 81 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-06 | 198 | 81 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.31e-05 | 166 | 81 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-05 | 172 | 81 | 5 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.56e-05 | 172 | 81 | 5 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-05 | 176 | 81 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.58e-05 | 191 | 81 | 5 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.65e-05 | 192 | 81 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.78e-05 | 194 | 81 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.78e-05 | 194 | 81 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.92e-05 | 196 | 81 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-05 | 196 | 81 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 2.99e-05 | 197 | 81 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.88e-04 | 156 | 81 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 62 | 81 | 3 | 91c49ae176d2a418a58398e9d5e55c77187cc2fb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 62 | 81 | 3 | 3275775572a65460b6248ee72b4c85e4d4dee424 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.28e-04 | 164 | 81 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 2.28e-04 | 164 | 81 | 4 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-04 | 166 | 81 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.49e-04 | 168 | 81 | 4 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-04 | 170 | 81 | 4 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-04 | 173 | 81 | 4 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-04 | 173 | 81 | 4 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.98e-04 | 176 | 81 | 4 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 179 | 81 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.24e-04 | 180 | 81 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 183 | 81 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 183 | 81 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 183 | 81 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 3.52e-04 | 184 | 81 | 4 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-04 | 185 | 81 | 4 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.60e-04 | 185 | 81 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-04 | 185 | 81 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.60e-04 | 185 | 81 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-04 | 186 | 81 | 4 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.67e-04 | 186 | 81 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 186 | 81 | 4 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 186 | 81 | 4 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.67e-04 | 186 | 81 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-04 | 187 | 81 | 4 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 3.75e-04 | 187 | 81 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 187 | 81 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.82e-04 | 188 | 81 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.82e-04 | 188 | 81 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-04 | 188 | 81 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 188 | 81 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.82e-04 | 188 | 81 | 4 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.82e-04 | 188 | 81 | 4 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Fetal_brain|World / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 189 | 81 | 4 | 643abc3c0afe1d3711b49bb5c1ab5951675884ad | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 3.90e-04 | 189 | 81 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 189 | 81 | 4 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 3.90e-04 | 189 | 81 | 4 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 189 | 81 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 3.90e-04 | 189 | 81 | 4 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-04 | 190 | 81 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-04 | 190 | 81 | 4 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.98e-04 | 190 | 81 | 4 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-04 | 190 | 81 | 4 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.98e-04 | 190 | 81 | 4 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-04 | 190 | 81 | 4 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.98e-04 | 190 | 81 | 4 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.06e-04 | 191 | 81 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.06e-04 | 191 | 81 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-04 | 191 | 81 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.06e-04 | 191 | 81 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.06e-04 | 191 | 81 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 191 | 81 | 4 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.06e-04 | 191 | 81 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 4.06e-04 | 191 | 81 | 4 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-04 | 191 | 81 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-04 | 191 | 81 | 4 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.06e-04 | 191 | 81 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.06e-04 | 191 | 81 | 4 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.06e-04 | 191 | 81 | 4 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.06e-04 | 191 | 81 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-04 | 191 | 81 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 4.06e-04 | 191 | 81 | 4 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-04 | 191 | 81 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.06e-04 | 191 | 81 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-04 | 191 | 81 | 4 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 4.06e-04 | 191 | 81 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.06e-04 | 191 | 81 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 4.14e-04 | 192 | 81 | 4 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-04 | 192 | 81 | 4 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.14e-04 | 192 | 81 | 4 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-04 | 192 | 81 | 4 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.14e-04 | 192 | 81 | 4 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 4.22e-04 | 193 | 81 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.22e-04 | 193 | 81 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.22e-04 | 193 | 81 | 4 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.76e-07 | 184 | 80 | 8 | 2321_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.87e-07 | 185 | 80 | 8 | 1114_DN | |
| Drug | glutamin | 4.88e-06 | 461 | 80 | 10 | CID000000738 | |
| Drug | AC1L9FY1 | 2.87e-05 | 101 | 80 | 5 | CID000444218 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.44e-05 | 174 | 80 | 6 | 5065_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 3177_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.42e-05 | 182 | 80 | 6 | 3887_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 4.70e-05 | 184 | 80 | 6 | 5671_DN | |
| Drug | carmustine; Up 200; 100uM; PC3; HT_HG-U133A | 5.14e-05 | 187 | 80 | 6 | 6883_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 5.46e-05 | 189 | 80 | 6 | 5084_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 4781_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7451_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 7259_UP | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6252_DN | |
| Drug | halofenate | 7.28e-05 | 4 | 80 | 2 | CID000033584 | |
| Drug | perfluoroundecanoic acid | 7.28e-05 | 4 | 80 | 2 | CID000077221 | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; HL60; HG-U133A | 7.46e-05 | 200 | 80 | 6 | 2018_DN | |
| Disease | diastolic blood pressure, systolic blood pressure | 7.48e-06 | 670 | 75 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | T-Cell Lymphoma | 8.62e-06 | 16 | 75 | 3 | C0079772 | |
| Disease | Malignant neoplasm of breast | NCOA2 GTF2A1 ARID1B KMT2D VWF C1orf87 ASL MACF1 SIK3 ARID1A EP300 EMSY | 1.60e-05 | 1074 | 75 | 12 | C0006142 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 6.34e-05 | 5 | 75 | 2 | C3281201 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Congenital small ears | 1.57e-04 | 41 | 75 | 3 | C0152423 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.57e-04 | 41 | 75 | 3 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 1.57e-04 | 41 | 75 | 3 | C0007138 | |
| Disease | Breast adenocarcinoma | 1.57e-04 | 41 | 75 | 3 | C0858252 | |
| Disease | C-reactive protein measurement | TLR10 RPGRIP1 SLC6A9 MACF1 CCDC168 CHD7 TAF4 PTBP1 NFAT5 GCN1 MAML3 | 2.26e-04 | 1206 | 75 | 11 | EFO_0004458 |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.27e-04 | 9 | 75 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Neuroblastoma | 2.36e-04 | 47 | 75 | 3 | C0027819 | |
| Disease | asthma, Eczema, allergic rhinitis | 2.61e-04 | 121 | 75 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | neuroblastoma (is_implicated_in) | 2.83e-04 | 10 | 75 | 2 | DOID:769 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.84e-04 | 50 | 75 | 3 | EFO_0022247 | |
| Disease | testosterone measurement | SOX15 NCOR2 URB1 ARID1B POLR1A GDF6 MACF1 CHD7 TAF4 ARID1A SS18 | 3.63e-04 | 1275 | 75 | 11 | EFO_0004908 |
| Disease | allergic rhinitis | 3.74e-04 | 133 | 75 | 4 | EFO_0005854 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.42e-04 | 139 | 75 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 4.54e-04 | 140 | 75 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.67e-04 | 141 | 75 | 4 | C0005684 | |
| Disease | triglycerides to total lipids in large HDL percentage | 4.86e-04 | 60 | 75 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.86e-04 | 60 | 75 | 3 | EFO_0022233 | |
| Disease | Coffin-Siris syndrome | 4.88e-04 | 13 | 75 | 2 | C0265338 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.19e-04 | 152 | 75 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 6.83e-04 | 156 | 75 | 4 | DOID:10283 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 7.33e-04 | 69 | 75 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | ischemia (implicated_via_orthology) | 8.46e-04 | 17 | 75 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | cognitive function measurement | SHISA9 NCOA2 ARID1B KMT2D PRPF40B FMN1 CHD7 GRIN2B PSMD14 SS18 MAML3 | 9.63e-04 | 1434 | 75 | 11 | EFO_0008354 |
| Disease | age at menopause | 1.04e-03 | 302 | 75 | 5 | EFO_0004704 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.06e-03 | 19 | 75 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | body surface area | 1.24e-03 | 643 | 75 | 7 | EFO_0022196 | |
| Disease | Leber Congenital Amaurosis | 1.42e-03 | 22 | 75 | 2 | C0339527 | |
| Disease | Huntington's disease (is_implicated_in) | 1.56e-03 | 23 | 75 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.56e-03 | 195 | 75 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.74e-03 | 93 | 75 | 3 | C1535926 | |
| Disease | Adenoid Cystic Carcinoma | 2.14e-03 | 100 | 75 | 3 | C0010606 | |
| Disease | Sezary Syndrome | 2.15e-03 | 27 | 75 | 2 | C0036920 | |
| Disease | congestive heart failure (is_implicated_in) | 2.15e-03 | 27 | 75 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.32e-03 | 103 | 75 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | lipoprotein measurement | 2.45e-03 | 105 | 75 | 3 | EFO_0004732 | |
| Disease | Breast Carcinoma | 2.49e-03 | 538 | 75 | 6 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STGVNMMSSVHLQQN | 316 | Q9H2P0 | |
| SMLHSAINSQNPMMS | 531 | Q09472 | |
| AINSQNPMMSENASV | 536 | Q09472 | |
| QQMNMNHNTMPSQFR | 2166 | Q09472 | |
| MNVSNLSQGVMLSHS | 36 | Q8TC20 | |
| LMIHSPQMSQFQSLT | 1066 | O60885 | |
| HINASNNSEPSRMNM | 661 | Q96GX5 | |
| QTDSMPTQLHSLSNM | 696 | Q9H116 | |
| MHNNAPRSQMATERD | 711 | Q6RI45 | |
| QPMNNSSSLMNTQAP | 1051 | Q8NFD5 | |
| AINEASMTPLHMAAN | 196 | A6NGH8 | |
| ANAATVLTNMAMQEP | 416 | Q5W041 | |
| TMVSLPSVQHMLQEQ | 186 | Q8N7E2 | |
| SLSNMVLAPLQSMQQ | 451 | Q9NPI6 | |
| GSLNQMNTQTMHPSQ | 371 | Q9P2D1 | |
| TQTMHQKPMTDNARQ | 46 | Q8N0U7 | |
| HAALQPMEGMASNQQ | 851 | Q68DA7 | |
| RNQSTDENSLHEPMM | 76 | Q7Z3E1 | |
| NLMLQVNMTSGHSSA | 246 | Q6GTS8 | |
| IMHPSMNQSSIAQDR | 736 | O14497 | |
| MLNTSMEPVTNSPQN | 4496 | Q8WXI7 | |
| TSQQMHHNAATAMAQ | 1691 | Q9Y618 | |
| MASNVTNKMDPHSVN | 1 | B2RXH8 | |
| MLQHPNQSGMSITHN | 881 | Q96JK9 | |
| SAQIQDSPMNNLMES | 361 | Q76N89 | |
| HQENMGQALSPDMLA | 356 | P04424 | |
| HMPQSPNVFNEHMTN | 4331 | Q2LD37 | |
| MDSNLDNLQTMLSSH | 391 | Q00613 | |
| MDKQNSQMNASHPET | 1 | O15162 | |
| VMATLPNFHQASLQM | 576 | P16050 | |
| QSPLNQSSMNAMGSL | 716 | Q92616 | |
| QLVTIMNPNTLMTHE | 551 | Q9UGL1 | |
| QTMVQMQHSGDNQPQ | 1006 | O94916 | |
| QSIFHQQSNMAPMNQ | 1306 | O94916 | |
| MPHMQLADSAEQNIN | 1931 | Q9UPN3 | |
| INFSAQNSMLPSQNM | 566 | O43313 | |
| QNSMLPSQNMTDNQT | 571 | O43313 | |
| NSRSMEMQDLASPHT | 26 | O95677 | |
| NHPSMMTINNLDGSQ | 221 | Q6AI39 | |
| ANQHNMPNLINTMME | 726 | Q8TD26 | |
| QMHVALNQTMPDDVQ | 611 | Q5T0N1 | |
| HLNSAAAQSPMGMNL | 1146 | Q86UU0 | |
| ENSSNIIPQQMAAHM | 2086 | Q99698 | |
| QPDHSSFLLQQMMQQ | 606 | Q13495 | |
| QSLDMLSQDTPSHAM | 381 | Q96JA4 | |
| HMVVAGMANSTPQQQ | 1191 | Q7Z589 | |
| QSMNMLNSNHELPDV | 196 | Q9NPA0 | |
| SGSSNAMNMNVQHER | 1971 | Q8NDH2 | |
| NNSHITPQDLSMAMQ | 376 | Q9BVL2 | |
| NMMVLGHEPRQTTSN | 166 | O00487 | |
| EPTNHAIIQTLMNSM | 396 | Q6KF10 | |
| AESHNMKNQQMDPFT | 581 | Q92541 | |
| MQAQAHAQPQTTMAP | 476 | O00268 | |
| CANHTITPDMSLQNM | 1406 | Q7Z3J3 | |
| PNSAHIMASNTMQVE | 221 | Q96KN7 | |
| HRQFPENSLQMMVQS | 886 | O95602 | |
| QMADGNQSQLAMNHL | 381 | Q9UKA9 | |
| MDIENLTISNAQMPH | 326 | Q9BXR5 | |
| SPQMAAQHNMVDDGS | 381 | Q9Y6U3 | |
| MHMISPSPNNQQATN | 566 | Q96SF7 | |
| SPSAGQMQMQHRTNL | 836 | Q9Y2K2 | |
| MDTRTPINNLHATQM | 221 | B4DS77 | |
| QLQATMPHLSMQQVL | 911 | O60287 | |
| DQMGQDNSQPMDTSN | 231 | Q99717 | |
| MNQPQHATELMVTSD | 1161 | Q9UK61 | |
| SAVNIMNGSQMHINP | 2181 | Q8IWZ3 | |
| SQSVMGNHPMHQQLS | 2416 | Q8IWZ3 | |
| AHTQSPMMQQSQANP | 1331 | Q15596 | |
| AVNALPQNMTSQMFS | 1551 | Q7KZ85 | |
| IQHMNASNMSAAATA | 126 | P52655 | |
| QMAQQNPKMHNSEIS | 66 | O60248 | |
| SQIPENSTSSQLMMN | 551 | O15062 | |
| DPVTLHNQALMNMDA | 286 | Q8N4P2 | |
| SSPATCHNNIMKQTM | 1041 | P04275 | |
| NQLNMTNSSMNMPSS | 141 | Q15532 | |
| MQNLMTTLPSQDASL | 711 | O14964 | |
| PQLMAQHSLAMAQNG | 71 | P48067 | |
| MPQNMVPLEDSNSHS | 656 | A0A0J9YWL9 | |
| MDNPSFAQDHQLQNM | 441 | Q6NWY9 | |
| HIQSLNMIESQMGPS | 616 | O43167 | |
| DPVTLHNQALMNMDA | 286 | Q86WT1 | |
| HMSALSQSQLISQMG | 176 | Q96NM4 | |
| PSASMSCQRQQQLMD | 36 | A6NGA9 | |
| MADGNQAQLAMSHLN | 381 | P26599 | |
| MQVQSALHSPTMQQG | 451 | O94900 | |
| SMAVSQPNLVMNHQH | 181 | Q9GZV5 | |
| MNHQHQQQMAPSTLS | 191 | Q9GZV5 | |
| SNQTMGSQMVSNIPQ | 591 | Q9BYP7 | |
| QRLAPSMAMVSNQGH | 3341 | O14686 | |
| QSVMNSPTATMNNTH | 881 | Q13224 |